Ruediger Rueger
- Molecular Biology
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Pathology and Forensic Medicine
- Cancer Research
- Co-authors
- Gwen NicholsJianguo ZhiFlorian HeilLyubomir T. VassilevJean‐Yves BlayAntoîne ItalianoNicolas PenelSteven A. Middleton
- Topics
- Melanoma and MAPK Pathways (6 papers)Cancer-related Molecular Pathways (4 papers)Sarcoma Diagnosis and Treatment (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyThe Lancet Oncology
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Ruediger Rueger
12 papers receiving 763 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Molecular Biology 500
- Oncology 422
- Pulmonary and Respiratory Medicine 215
- Pathology and Forensic Medicine 98
- Cancer Research 93
Countries citing papers authored by Ruediger Rueger
This map shows the geographic impact of Ruediger Rueger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger Rueger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger Rueger more than expected).
Fields of papers citing papers by Ruediger Rueger
This network shows the impact of papers produced by Ruediger Rueger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger Rueger. The network helps show where Ruediger Rueger may publish in the future.
Co-authorship network of co-authors of Ruediger Rueger
This figure shows the co-authorship network connecting the top 25 collaborators of Ruediger Rueger. A scholar is included among the top collaborators of Ruediger Rueger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruediger Rueger. Ruediger Rueger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 41 | |
| 3 | 55 | |
| 4 | 122 | |
| 5 | Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism studybreakdown → | 455 |
| 6 | 6 | |
| 7 | 10 | |
| 8 | 8 | |
| 9 | 15 | |
| 10 | 1 | |
| 11 | 18 | |
| 12 | 30 |
About Ruediger Rueger
Ruediger Rueger is a scholar working on Oncology, Biophysics and Microbiology, having authored 12 papers that have together received 769 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Cancer-related Molecular Pathways (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (422 citations), Molecular Biology (500 citations) and Pulmonary and Respiratory Medicine (215 citations). Ruediger Rueger has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Gwen Nichols, Jianguo Zhi, Florian Heil, Lyubomir T. Vassilev, Jean‐Yves Blay, Antoîne Italiano, Nicolas Penel, Steven A. Middleton, Axel Le Cesne and Meichun Ding. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.